Stéphanie Sigaut

Stéphanie Sigaut

Auto-generated profile, based on publicly available information

Stéphanie Sigaut

Anesthesiology and Intensive Care, Beaujon Hospital, Assistance Publique—Hôpitaux de Paris, Clichy, Île-de-France, France

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Anesthesiology
Verified
Journal Article
Closed access
SSStéphanie Sigaut
Stéphanie Sigaut
BTBenjamin Tremey
Benjamin Tremey
AOAlexandre Ouattara
Alexandre Ouattara
RCRoland Couturier
Roland Couturier
CTChristian Taberlet
Christian Taberlet
MFMarc Fischler
Marc Fischler
Background: The optimal dose of tranexamic acid (TA) is still an issue. The authors compared two doses of TA during cardiac surgery in a multicenter, double-blinded, randomized study. Methods: Patients were stratified according to transfusion risk, then randomized to two TA doses: 10 mg/kg bolus followed by 1 mg·kg−1·h−1 infusion (low dose) until the end of surgery or 30 mg/kg bolus followed by 16 mg·kg−1·h−1 infusion (high dose). The primary endpoint was the incidence of blood product transfusion up to day 7. Secondary ones were incidences of transfusion for each type of blood product and amounts transfused, blood loss, repeat surgery, TA-related adverse events, and mortality. Results: The low-dose group comprised 284 patients and the high-dose one 285. The primary endpoint was not significantly different between TA doses (63% for low dose vs. 60% for high dose; P = 0.3). With the high dose, a lower incidence of frozen plasma (18 vs. 26%; P = 0.03) and platelet concentrate (15 vs. 23%; P = 0.02) transfusions, lower amounts of blood products (2.5 ± 0.38 vs. 4.1 ± 0.39; P = 0.02), fresh frozen plasma (0.49 ± 0.14 vs.1.07 ± 0.14; P = 0.02), and platelet concentrates transfused (0.50 ± 0.15 vs. 1.13 ± 0.15; P = 0.02), lower blood loss (590 ± 50.4 vs. 820 ± 50.7; P = 0.01), and less repeat surgery (2.5 vs. 6%; P = 0.01) were observed. These results are more marked in patients with a high risk for transfusion. Conclusions: A high dose of TA does not reduce incidence of blood product transfusion up to day 7, but is more effective than a low dose to decrease transfusion needs, blood loss, and repeat surgery.

18 November 2009 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
SSStephanie Sigaut
Stephanie Sigaut
ASAlia Skhiri
Alia Skhiri
ISIda Stany
Ida Stany
JGJonathan Golmar
Jonathan Golmar
YNYves Nivoche
Yves Nivoche
SDSouhayl Dahmani
Souhayl Dahmani

19 March 2015 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
Bobbi FleissBobbi Fleiss
Bobbi Fleiss
CTCally Tann
Cally Tann
VDVincent Degos
Vincent Degos
SSStéphanie Sigaut
Stéphanie Sigaut
JSJuliette Van Steenwinckel
Juliette Van Steenwinckel
PGPierre Gressens
Pierre Gressens
Perinatal insults are a leading cause of infant mortality and amongst survivors are frequently associated with neurocognitive impairment, cerebral palsy (CP), and seizure disorders. The events leading to perinatal brain injury are multifactorial. This review describes how one subinjurious factor affecting the brain sensitizes it to a second injurious factor, causing an exacerbated injurious cascade. We will review the clinical and experimental evidence, including observations of high rates of maternal and fetal infections in term‐born infants with neonatal encephalopathy and cerebral palsy. In addition, we will discuss preclinical evidence for the sensitizing effects of inflammation on injuries, such as hypoxia–ischaemia, our current understanding of the mechanisms underpinning the sensitization process, and the possibility for neuroprotection.

1 July 2017 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
VCVibol Chhor
Vibol Chhor
RMRaffaella Moretti
Raffaella Moretti
TCTifenn Le Charpentier
Tifenn Le Charpentier
SSStephanie Sigaut
Stephanie Sigaut
SLSophie Lebon
Sophie Lebon
Bobbi FleissBobbi Fleiss
Bobbi Fleiss
The cognitive and behavioural deficits caused by traumatic brain injury (TBI) to the immature brain are more severe and persistent than TBI in the mature brain. Understanding this developmental sensitivity is critical as children under four years of age sustain TBI more frequently than any other age group. Microglia (MG), resident immune cells of the brain that mediate neuroinflammation, are activated following TBI in the immature brain. However, the type and temporal profile of this activation and the consequences of altering it are still largely unknown. In a mouse model of closed head weight drop paediatric brain trauma, we characterized i) the temporal course of total cortical neuroinflammation and the phenotype of ex vivo isolated CD11B-positive microglia/macrophage (MG/MΦ) using a battery of 32 markers, and ii) neuropathological outcome 1 and 5days post-injury. We also assessed the effects of targeting MG/MΦ activation directly, using minocycline a prototypical microglial activation antagonist, on these processes and outcome. TBI induced a moderate increase in both pro- and anti-inflammatory cytokines/chemokines in the ipsilateral hemisphere. Isolated cortical MG/MΦ expressed increased levels of markers of endogenous reparatory/regenerative and immunomodulatory phenotypes compared with shams. Blocking MG/MΦ activation with minocycline at the time of injury and 1 and 2days post-injury had only transient protective effects, reducing ventricular dilatation and cell death 1day post-injury but having no effect on injury severity at 5days. This study demonstrates that, unlike in adults, the role of MG/MΦ in injury mechanisms following TBI in the immature brain may not be negative. An improved understanding of MG/MΦ function in paediatric TBI could support translational efforts to design therapeutic interventions.

20 March 2014 in Biochemical Society Transactions
Verified
Journal Article
Closed access
PDF file
JSJuliette Van Steenwinckel
Juliette Van Steenwinckel
ASAnne-Laure SCHANG
Anne-Laure SCHANG
SSStéphanie Sigaut
Stéphanie Sigaut
VCVibol Chhor
Vibol Chhor
VDVincent Degos
Vincent Degos
PGPierre Gressens
Pierre Gressens
Epidemiological studies have shown a strong association between perinatal infection/inflammation and brain damage in preterm infants and/or neurological handicap in survivors. Experimental studies have shown a causal effect of infection/inflammation on perinatal brain damage. Infection including inflammatory factors can disrupt programmes of brain development and, in particular, induce death and/or blockade of oligodendrocyte maturation, leading to myelin defects. Alternatively, in the so-called multiple-hit hypothesis, infection/inflammation can act as predisposing factors, making the brain more susceptible to a second stress (sensitization process), such as hypoxic–ischaemic or excitotoxic insults. Epidemiological data also suggest that perinatal exposure to inflammatory factors could predispose to long-term diseases including psychiatric disorders.

11 February 2013 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
VDVincent Degos
Vincent Degos
SPStéphane Peineau
Stéphane Peineau
CNCora Nijboer
Cora Nijboer
AKAngela M. Kaindl
Angela M. Kaindl
SSStéphanie Sigaut
Stéphanie Sigaut
PGPierre Gressens
Pierre Gressens